33
Views
21
CrossRef citations to date
0
Altmetric
Review

Matrix Metalloproteinase Inhibitor Drugs

&
Pages 205-230 | Published online: 04 Mar 2005

Bibliography

  • DOLLERY CM, MCEWAN JR, HENNEY AM: Matrix metalloproteinases and cardiovascular disease. Circ. Res. (1995) 77(5):863–868.
  • BECKETT RP, DAVIDSON AH, DRUMMOND AH, HUXLEY P, WHITTAKER M: Recent advances in matrix metalloproteinase inhibitor research. Drug Discovery Today (1996) 1(1):16–26.
  • An excellent review article broadly covering the field of MMPIs with discussions surrounding numerous compounds of potential therapeutic interest.
  • BUIS SON AC, GILLES C, POLETTE M, et al.: Wound repair-induced expression of stromelysins is associated with the acquisition of a mesenchymal phenotype in human respiratory epithelial cells. Laboratory Invest. (1996) 74(3):658–669.
  • BUISSON AC, ZAHM JM, POLETTE M, et al. : Gelatinase B is involved in the in vitro wound repair of human respiratory epithelium. J. Cell. Physiol. (1996) 166(2):413–426.
  • CHEUNG NT, MATTEY DL, DAWES PT, TAYLOR DJ: Serum pro-matrix metalloproteinase 3 in rheumatoid arthritis: a reflection of local or systemic inflammation Arthritis Rheum. (1996) 39(5):884–885.
  • ZUCKER S, LYSIK RM, ZARRABI HM, et al.: Plasma assay of matrix metalloproteinases (1VIMPs) and MMP-inhibitor complexes in cancer. Ann. NY Acad. Sci. (1994) 732:248–262.
  • TYAGI SC, KUMAR SG, BANKS J, FORTSON W: Co-expression of tissue inhibitor and matrix metalloproteinase in myocardium.i Ma Cell. Cardiol. (1995) 27(10):2177–2189.
  • IREDALE JP, GODDARD S, MURPHY G, BENYON RC, ARTHUR MJP: Tissue inhibitor of metalloproteinase-1 and interstitial collagenase expression in autoimmune chronic active hepa-titis and activated human hepatic lipocytes. Clin. Sci. (1995) 89(1):75–81.
  • HOEBEN E, VANAELST I, SWINNEN JV, OPDENAKKER G, VERHOEVEN G: Gelatinase A secretion and its control in peritubular and Sertoli cell cultures: effects of hormones, second messengers and inducers of cytokine production. Ma Cell. Endocrinol. (1996) 118(1-2):37–46.
  • SCHELLER M, ZIMMERMANN B, BERNIMOULIN JP, SCHOLZ P: Induction of metalloprotei-nase activity, cartilage matrix degradation and inhibition of endochondral mineralization in vitro by E. coil lipopolysaccharide is mediated by interleukin 1 alpha. Cytokine (1995) 7(4):331–337.
  • HURLEY MM, MARCELLO K, ABREU C, et al.: Transcriptional regulation of the collagenase gene by basic fibroblast growth factor in osteoblastic MC3t3-E1 cells. Biochem. Biophys. Res. Commun. (1995) 214(2):331–339.
  • KUROGI T, NABESHIMA K, KATAOKA H, OKADA Y, KOONO M: Stimulation of gelatinase B and tissue inhibitors of metalloproteinase (TIMP) production in co-culture of human osteosar-coma cells and human fibroblasts: gelatinase B production was stimulated via up-regulation of fibroblast growth factor (FGF) receptor. Int. 1 Cancer (1996) 66(1):82–90.
  • CAWSTON T, PLUMPTON T, CURRY V, ELLIS A, POWELL L: Role of TIMP and MMP inhibition in preventing connective tissue breakdown. Ann. NY Acad. Sci. (1994) 732:75–83.
  • LIN CQ, BISSELL MJ: Multi-faceted regulation of cell differentiation by extracellular matrix. FASEB 1 (1993) 7:737–743.
  • HARDING KG, BALES, LLEWELLYN M, BAGGOTT J, ROBBINS KA: Pilot study of Clostridium collagenase (collagenase ABC(R)) ointment in the debridement of dermal ulcers. Clin. Drug Invest. (1996) 11(3):139–144.
  • WECKROTH M, VAHERI A, LAUHARANTA J, SORSA T, KONTTINEN YT: Matrix metallo-proteinases, gelatinase and collagenase, in chronic leg ulcers. I Invest. Dermatol. (1996) 106(5):1119–1124.
  • AHRENS D, KOCH AE, POPE RM, STEINPICARELLA M, NIEDBALA MJ: Expression of matrix metalloproteinase 9(96 kDa gelatinase B) in human rheumatoid arthritis. Arthritis Rheum. (1996) 39(9):1576–1587.
  • BLASER J, TRIEBEL S, MAASJOSTHUSMANN U, et al.: Determination of metalloproteinases, plasminogen-activators and their inhibitors in the synovial fluids of patients with rheumatoid arthritis during chemical synoviorthesis. Clinica Chimica Acta (1996) 244(1):17–33.
  • HEWSON AK, SMITH T, LEONARD JP, CUZNER ML: Suppression of experimental allergic encephalomyelitis in the Lewis rat by the matrix metalloproteinase inhibitor Ro 31-9790. Inflamm. Res. (1995) 44(8):345–349.
  • MAEDA A, SOBEL RA: Matrix metalloproteinases in the normal human central nervous system, microglial nodules, and multiple sclerosis lesions. J. Neuropathol. Exp. Neurol. (1996) 55(3):300–309.
  • RAY JM, STETLER-STEVENSON WG: Matrix metalloproteinases and malignant disease: recent developments. Exp. Opin. Invest. Drugs (1996) 5(3):323–335. This paper provides pivotal data regarding the role of MMPs in cancer.
  • MORPHY JR, MILLICAN TA, PORTER JR: Matrix metalloproteinase inhibitors: current status. Curr. Med. Chem. (1995) 2:743–762.
  • An excellent review covering various classes of MMPIs, the structure activity relationships surrounding these compounds, and their potential role in the regulation of diseases.
  • FOLICMAN J, SHING Y: Angiogenesis. J. Biol. Chem. (1992) 267:10931–10934.
  • MANIET AR, BANKA VS: Restenosis: perspective for prevention_ Primary Cardiol. (1992) 18:77–85.
  • MAINARDI CL: Collagenase in rheumatoid arthritis. Ann. NY Acad. Sci. (1985) 460:345–354.
  • Woessner JF, Howell DS (Eds.), Marcel Dekker, New York (1993):385–408.
  • BARAGI VI, BROTT DA, QIU L, CONROY MC, LALWANI ND: Confocal laser scanning immunofluorescence imaging for quantitation of stromelysin in human synovial fibroblasts. Ann. NY Acad. Sci. (1994) 732:348-350. This article addresses the role of MMPs in arthritis.
  • WOOLEY DE, BRINKERHOFF CE, MAINARDI CL: Collagenase production by rheumatoid synovial cells. Ann. Rheum. Dis. (1977) 38:262–270.
  • DAYER JM, KRANE SM, RUSSELL ROG: Production of collagenase and prostaglandins by isolated adherent rheumatoid synovial cells. Proc. Natl. Acad. Sci. USA (1976) 73:945–949.
  • BRAVERMAN IM, SIBLE J: Role of microcirculation in the treatment and pathogenesis of psoriasis. J. Invest. Dermatol. (1982) 78:12–17.
  • SCHUBERT C, CHRISTOPHERS E, SWENSSON 0, ISEI T: Transendothelial cell diapedesis of neutrophils in inflamed human skin. Arch. Dermatol. Res. (1989) 281:475–481.
  • DARMIENTO J, DICOLANDREA T, DALAL SS, et al.: Collagenase expression in transgenic mouse skin causes hyperkeratosis and acanthosis and increases susceptibility to tumorigenesis. Ma Cell. Biol. (1995) 15(10):5732–5739.
  • GALARDY RE, CASSABONNE ME, GIESE C, et al.: Low molecular weight inhibitors in corneal ulceration. Ann. NY Acad. Sci. (1994) 732:315–323.
  • This article addresses the potential utility of MMPIs as therapeutic agents affecting wound healing processes.
  • SAARIALHOKERE UK, VAALAMO M, PUOLAKKAINEN P, et al.: Enhanced expression of matrilysin, collagenase, and stromelysin-1 in gastrointestinal ulcers. Am. J. Pathol. (1996) 148(2):519–526.
  • FIDLER U, NAITO S, PATHAK S: Orthotopic implantation is essential for the selection, growth and metastasis of human renal cell cancer in nude mice. Cancer Metastasis Rev. (1990) 9:149–165.
  • LIOTTA LA, STEEG PS, STETLER-STEVENSON WG: Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell (1991) 64:327–336.
  • RAY JM, STETLER-STEVENSON WG: The role of matrix metalloproteases and their inhibitors in tumor invasion, metastasis and angiogenesis. Eur. Resp. J. (1994) 7:2062-2072. This article addresses the role of MMPs in cell migration and the effects of MMPIs on these pathophysiological processes.
  • BENDECK MP, ZEMPO N, CLOWES AW, GALARDY RE, REIDY MA: Smooth muscle cell migration and matrix metalloproteinase expression after arterial injury in the rat. Circ. Res. (1994) 75(3):539–545.
  • This paper represents a proof of concept regarding the role of MMPs in the process of restenosis.
  • STRAUSS BH, ROBINSON R, BATCHELOR WB, et al.: In vivo collagen turnover following experimental balloon angioplasty injury and the role of matrix metalloproteinases. Circ. Res. (1996) 79(3):541–550.
  • ZEMPO N, KOYAMA N, KENAGY RD, LEA HJ, CLOWES AW: Regulation of vascular smooth muscle cell migration and proliferation in vitro and in injured rat arteries by a synthetic matrix metalloproteinase inhibitor. Arterioscler. Thromb. Vasc. Biol. (1996) 16:28-33. This is among the first articles available claiming the utility of MMPIs in the prevention of restenosis.
  • FIEDLER U, ELLIS LM: The implications of angiogenesis for the biology and therapy of cancer metastasis. Cell (1994) 79:185–188.
  • BROOKS PC, CLARK RA, CHERESH DA: Requirement of vascular integrin alpha v beta 3 for angiogenesis. Science (1994) 264:569–571.
  • PORTER JR, MILLICAN TA, MORPHY JR: Recent developments in matrix metalloproteinase inhibitors. Exp. Opin. Ther. Patents (1995) 5(12):1287–1296.
  • This is an excellent review article covering the current status of matrix metalloproteinase inhibitor research.
  • ANDERSON IC, SHIPP MA, DOCHERTY AJP, TEICHER BA: Combination therapy including a gelatinase inhibitor and cytotoxic agent reduces local invasion and metastasis of murine Lewis lung carcinoma. Cancer Res. (1996) 56:715–718.
  • This article demonstrates the ability of MMPIs to work in combination with cytotoxic chemotherapeutic agents.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.